Lucid Diagnostics LUCD Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Lucid Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lucid Diagnostics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lucid Diagnostics's total equity?
- Lucid Diagnostics (LUCD) reported total equity of $4M in Q1 2026.
- How has Lucid Diagnostics's total equity changed year-over-year?
- Lucid Diagnostics's total equity increased by 174.4% year-over-year, from -$5.38M to $4M.
- What is the long-term trend for Lucid Diagnostics's total equity?
- Over 5 years (2020 to 2025), Lucid Diagnostics's total equity has grown at a -4.2% compound annual growth rate (CAGR), from -$13.52M to $10.94M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.